Literature DB >> 21740754

Ultrasonic destruction of albumin microbubbles enhances gene transfection and expression in cardiac myocytes.

Guo-zhong Wang1, Jing-hua Liu, Shu-zheng Lü, Yun Lü, Cheng-jun Guo, Dong-hui Zhao, Dong-ping Fang, Dong-fang He, Yuan Zhou, Chang-jiang Ge.   

Abstract

BACKGROUND: It has been proven that ultrasonic destruction of microbubbles can enhance gene transfection efficiency into the noncardiac cells, but there are few reports about cardiac myocytes. Moreover, the exact mechanisms are not yet clear; whether the characteristic of microbubbles can affect the gene transfection efficiency or not is still controversial. This study was designed to investigate whether the ultrasound destruction of gene-loaded microbubbles could enhance the plasmids carried reporter gene transfection in primary cultured myocardial cell, and evaluate the effects of microbubbles characteristics on the transgene expression in cardiac myocytes.
METHODS: The β-galactosidase plasmids attached to the two types of microbubbles, air-contained sonicated dextrose albumin (ASDA) and perfluoropropane-exposed sonicated dextrose albumin (PESDA) were prepared. The gene transfection into cardiac myocytes was performed in vitro by naked plasmids, ultrasound exposure, ultrasonic destruction of gene-loaded microbubbles and calcium phosphate precipitation, and then the gene expression and cell viability were analyzed.
RESULTS: The ultrasonic destruction of gene-loaded microbubbles enhanced gene expression in cardiac myocytes compared with naked plasmid transfection ((51.95 ± 2.41) U/g or (29.28 ± 3.65) U/g vs. (0.84 ± 0.21) U/g, P < 0.01), and ultrasonic destruction PESDA resulted in more significant gene expression than ASDA ((51.95 ± 2.41) U/g vs. (29.28 ± 3.65) U/g, P < 0.05). Ultrasonic destruction of microbubbles during calcium phosphate precipitation gene transfection enhanced β-galactosidase activity nearly 8-fold compared with calcium phosphate precipitation gene transfection alone ((111.35 ± 11.21) U/g protein vs. (14.13 ± 2.58) U/g protein, P < 0.01). Even 6 hours after calcium phosphate precipitation gene transfection, ultrasound-mediated microbubbles destruction resulted in more intense gene expression ((35.63 ± 7.65) U/g vs. (14.13 ± 2.58) U/g, P < 0.05).
CONCLUSIONS: Ultrasonic destruction of microbubbles might be a promising method for the delivery of non-viral DNA into cardiac myocytes, and the gene tranfection is related to the characteristics of microbubbles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21740754

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  In vitro gene delivery with ultrasound-triggered polymer microbubbles.

Authors:  Michael Cochran; Margaret A Wheatley
Journal:  Ultrasound Med Biol       Date:  2013-04-03       Impact factor: 2.998

2.  Focused ultrasound blood brain barrier opening mediated delivery of MRI-visible albumin nanoclusters to the rat brain for localized drug delivery with temporal control.

Authors:  Megan C Rich; Jennifer Sherwood; Aundrea F Bartley; Quentin A Whitsitt; Magdelene Lee; W R Willoughby; Lynn E Dobrunz; Yuping Bao; Farah D Lubin; Mark Bolding
Journal:  J Control Release       Date:  2020-05-05       Impact factor: 9.776

3.  PiggyBac transposon-mediated gene delivery efficiently generates stable transfectants derived from cultured primary human deciduous tooth dental pulp cells (HDDPCs) and HDDPC-derived iPS cells.

Authors:  Emi Inada; Issei Saitoh; Satoshi Watanabe; Reiji Aoki; Hiromi Miura; Masato Ohtsuka; Tomoya Murakami; Tadashi Sawami; Youichi Yamasaki; Masahiro Sato
Journal:  Int J Oral Sci       Date:  2015-09-14       Impact factor: 6.344

4.  Localized Delivery of shRNA against PHD2 Protects the Heart from Acute Myocardial Infarction through Ultrasound-Targeted Cationic Microbubble Destruction.

Authors:  Li Zhang; Zhenxing Sun; Pingping Ren; Manjie You; Jing Zhang; Lingyun Fang; Jing Wang; Yihan Chen; Fei Yan; Hairong Zheng; Mingxing Xie
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.